Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

Kura Oncology Taps Foundation Medicine to ID Patients for Cancer Drug Trial

Foundation Medicine's SmartTrials Precision Enrollment program will ID patients with HRAS mutant squamous cell carcinoma of the head and neck.

CRISPR Therapeutics, Neon Therapeutics Enter Research Collaboration

The two companies plan to combine their respective gene editing and neoantigen discover technologies in order to develop new T cell therapies for cancer patients.

Sema4, GNS Healthcare Collaborate on Machine Learning for Therapy Discovery

The companies plan to use machine learning and simulation to study disease drivers and identify existing and new therapies, focusing first on cardiovascular disease.

Basket Study Supported Keytruda Pan-Cancer Indication But Challenges Remain

Premium

At the WIN Symposium, a Merck executive detailed how data from a basket study led to the first pan-cancer, biomarker-informed cancer drug.

Genome Canada, Pharma Partners Commit C$33M to Structural Genomics Consortium

The consortium conducts basic science on the structures of human proteins and releases the research to the public.

Jun 06, 2017

New Precision Oncology Options Emerge at ASCO in First-Line EGFR-Mutated, ALK-Positive Lung Cancer

Premium

Jun 04, 2017

ASCO Expands TAPUR Sites; Inks Collaborations to Investigate Precision Oncology Globally

May 31, 2017

ImiDomics, Celgene Partner on Immune-Mediated Inflammatory Disease Research

May 25, 2017

Targeting ANGPTL3 Could Lead to Development of Heart Disease Therapies

May 15, 2017

Thermo Fisher Buying Pharma Contract Development and Manufacturing Firm Patheon for $7.2B

Apr 21, 2017

Aevi Genomic Medicine IDs Best Responder Subset For ADHD Drug

Premium

Apr 20, 2017

Single-Cell RNA-Seq Reveals New Dendritic Cell, Monocyte Subtypes

Apr 18, 2017

Pfizer, HitGen Partner to Develop DNA-Encoded Libraries

Apr 11, 2017

Startup 1Cellbio Inks Single-Cell Sequencing Collaboration With UCB

Apr 03, 2017

HER2 Mutant Basket Trial Confirms Drug Response Depends on Mutation, Cancer Type

Mar 30, 2017

Foundation Medicine, Bristol-Myers Squibb Collaborate on Tumor Profiling

Mar 30, 2017

Tango Therapeutics Launches With $55M Series A Financing

Mar 28, 2017

Aldevron Licenses Tech for Development of Multiple Myeloma Treatments

Mar 23, 2017

GlaxoSmithKline, Regeneron Partner to Sequence Entire UK Biobank

Mar 20, 2017

CRISPR Method Used to Detect Synthetic Lethalities in Cancer

Mar 15, 2017

Metrion, Concept Life Sciences Partner on Ion Channel Drug Discovery Services

Mar 14, 2017

Editas, Allergan Ink $90M CRISPR-Based Eye Drug Deal

Mar 09, 2017

SenzaGen, AstraZeneca Partner on Genomic Test for Respiratory Irritants

Mar 06, 2017

MedDay Acquires Health Assets of Profilomic

Mar 01, 2017

HD Biosciences, Luxcel Ink Marketing Deal for Mitochondria Assays